share_log

AEye Shares Are Falling Today: What You Need To Know

AEye Shares Are Falling Today: What You Need To Know

AEye的股票今天下跌:你需要知道的事項
Benzinga ·  2024/12/31 05:39

AEye, Inc. (NASDAQ:LIDR) shares are trading lower following the company's announcement it had updated its maximum private placement agreement to generate up to $5.23 million in proceeds under an at-market sales agreement.

AEye公司(納斯達克:LIDR)股票在公司宣佈已更新其最大定向增發協議以通過市場銷售協議生成高達523萬美元的收益後,股價下跌。

What To Know: In a Form 8-K filing, AEye disclosed that it had filed a prospectus supplement to increase the maximum number of shares issuable under its At Market Issuance Sales Agreement with A.G.P./Alliance Global Partners. This update reflects the company's plan to issue additional shares of common stock as part of its ongoing fundraising efforts.

要知道的是:在一份8-K表格的文件中,AEye披露已提交一份招股說明書補充,以增加根據與A.G.P./Alliance Global Partners簽訂的市場發售銷售協議可發行的最大股票數量。此次更新反映了公司計劃作爲其持續籌款努力的一部分,發行更多普通股的計劃。

The issuance and sale of these shares will be conducted under a previously filed registration statement with the SEC, which became effective in September 2023.

這些股票的發行和出售將根據與SEC之前提交的註冊聲明進行,該聲明於2023年9月生效。

Investors potentially reacted negatively to the announcement, as the prospect of increased share issuance often raises concerns about dilution. AEye's decision to pursue this private placement comes as the company seeks to raise capital to support its operations and strategic initiatives.

投資者對這一公告可能反應消極,因爲增加股票發行的前景通常會引發對稀釋的擔憂。AEye決定進行這次定向增發,是因爲公司希望籌集資金以支持其運營和戰略計劃。

LIDR Price Action: AEye shares closed down 17.16% at $1.69 Monday, according to Benzinga Pro. Shares are continuing to drop after hours, 4.14% at $1.62 at publication.

LIDR價格動態:根據Benzinga Pro,AEye股票週一收盤下跌17.16%,報1.69美元。在發佈時,股價在盤後繼續下跌,跌幅4.14%,報1.62美元。

big
  • If You Invested $1,000 In Bitcoin (And Other Crypto) When Jim Cramer Said Anyone Holding Was 'An Idiot', Here's How Much You'd Have Now
  • 如果你在吉姆·克雷默說任何持有比特幣(比特幣和其他加密貨幣)的人都是'傻瓜'時投資了1000美元,下面是你現在擁有的金額。

Photo: Shutterstock.

照片:Shutterstock。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論